When to Treat First in Metastatic NSCLC? - Top-Institutions - MDSpire

When to Treat First in Metastatic NSCLC?

Real-world data show flexible sequencing of immunotherapy and local radical treatment can achieve durable survival in selected patients with synchronous oligometastatic NSCLC

  • By

  • Jo Cavallo

  • January 13, 2026

  • 5 min

Share

Top Institutions in Pulmonary

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Medical Oncology
    • Thoracic Oncology
    • Immunotherapy

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Medical Oncology
    • Thoracic Oncology
    • Immunotherapy

  • #3

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Medical Oncology
    • Thoracic Oncology
    • Radiation Oncology

  • #4

    Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
    Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

    Baltimore, MD

    Key Differentiators

    • Medical Oncology
    • Thoracic Oncology
    • Immunotherapy

  • #5

    University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center
    University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center

    San Francisco, CA

    Key Differentiators

    • Medical Oncology
    • Thoracic Oncology
    • Immunotherapy

Original Source(s)

When to Treat First in Metastatic NSCLC?

  • by Jo Cavallo

  • January 13, 2026

Related Content

Sleep Study Cutoffs May Guide Discharge

Preoperative sleep study values may distinguish lower-risk children within a population for whom overnight admission is currently routine.

Defining early carcinogenic markers for the prediction of the hazard potential of mineral fibres in an in vitro human 3D bronchial model

COPD Severity Tied to Life Expectancy

A pooled US cohort study estimated years of life lost across airflow obstruction severity, including among adults who never smoked.